{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,11]],"date-time":"2024-09-11T23:37:52Z","timestamp":1726097872475},"reference-count":15,"publisher":"American Psychiatric Association Publishing","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["AJP"],"published-print":{"date-parts":[[1999,7,1]]},"DOI":"10.1176\/ajp.156.7.1086","type":"journal-article","created":{"date-parts":[[2022,7,29]],"date-time":"2022-07-29T16:19:12Z","timestamp":1659111552000},"page":"1086-1090","source":"Crossref","is-referenced-by-count":4,"title":["A Dilemma Born of Progress: Switching From Clozapine to a Newer Antipsychotic"],"prefix":"10.1176","volume":"156","author":[{"given":"Seth","family":"Rafal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming T.","family":"Tsuang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"Jr.","given":"William T.","family":"Carpenter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"230","reference":[{"key":"R1567BABDBEDC","doi-asserted-by":"crossref","unstructured":"Duckworth K, Nair V, Patel JK, Goldfinger SM: Lost time, found hope and sorrow: the search for self, connection and purpose during \u201cawakenings\u201d on the new antipsychotics. Harv Rev Psychiatry 1997; 5:227\u2013233","DOI":"10.3109\/10673229709000305"},{"key":"R1567BABCAHDG","unstructured":"Kane JM, Tamminga CA, Schooler NR, Casey DE: Choosing among old and new antipsychotics. J Clin Psychiatry 1996; 57:427\u2013438"},{"key":"atypb1","doi-asserted-by":"crossref","unstructured":"Kane J, Honigfeld G, Singer J, Meltzer H: Clozapine for the treatment-resistant schizophrenic: a double-blind comparison with chlorpromazine. Arch Gen Psychiatry 1988; 45:789\u2013796","DOI":"10.1001\/archpsyc.1988.01800330013001"},{"key":"atypb2","doi-asserted-by":"crossref","unstructured":"Breier A, Buchanan RW, Kirkpatrick B, Davis OR, Irish D, Summerfelt A, Carpenter WT Jr: Effects of clozapine on positive and negative symptoms in outpatients with schizophrenia. Am J Psychiatry 1994; 151:20\u201326","DOI":"10.1176\/ajp.151.1.20"},{"key":"R1567BABDGIAB","doi-asserted-by":"crossref","unstructured":"Falloon IRH: Developing and maintaining adherence to long-term drug-taking regimens. Schizophr Bull 1984; 10:412\u2013417","DOI":"10.1093\/schbul\/10.3.412"},{"key":"atypb3","doi-asserted-by":"crossref","unstructured":"Eisenthal S, Emery R, Lazare A, Udin H: \u201cAdherence\u201d and the negotiated approach to patienthood. Arch Gen Psychiatry 1979; 36:393\u2013398","DOI":"10.1001\/archpsyc.1979.01780040035003"},{"key":"R1567BABBBEDI","doi-asserted-by":"crossref","unstructured":"Corrigan PW, Liberman RP, Engel JD: From noncompliance to collaboration in the treatment of schizophrenia. Hosp Community Psychiatry 1990; 41:1203\u20131211","DOI":"10.1176\/ps.41.11.1203"},{"key":"R1567BABBFBIE","doi-asserted-by":"crossref","unstructured":"Beasley CM, Sanger T, Satterlee W, Tollefson G, Tran P, Hamilton S, Olanzapine HGAD Study Group: Olanzapine versus placebo: results of a double-blind, fixed-dose olanzapine trial. Psychopharmacology (Berl) 1996; 124:159\u2013167","DOI":"10.1007\/BF02245617"},{"key":"atypb4","doi-asserted-by":"crossref","unstructured":"Meltzer HY, Fibiger HC: A new atypical antipsychotic drug. Neuropsychopharmacology 1996; 14:83\u201385","DOI":"10.1016\/0893-133X(95)00197-L"},{"key":"R1567BABDCFCB","doi-asserted-by":"crossref","unstructured":"Beasley CM, Tollefson G, Tran P, Satterlee W, Sanger T, Hamilton S, Olanzapine HGAD Study Group: Olanzapine versus placebo and haloperidol: acute phase results of the North American double-blind olanzapine trial. Neuropsychopharmacology 1996; 14:111\u2013123","DOI":"10.1016\/0893-133X(95)00069-P"},{"key":"R1567BABDEEEB","doi-asserted-by":"crossref","unstructured":"Awad AG, Hogan TP: Subjective response to neuroleptics and the quality of life: implications for treatment outcome. Acta Psychiatr Scand Suppl 1994; 380:27\u201332","DOI":"10.1111\/j.1600-0447.1994.tb05828.x"},{"key":"R1567BABBBFJI","doi-asserted-by":"crossref","unstructured":"Budd RJ, Hughes ICT, Smith JA: Health beliefs and compliance with antipsychotic medication. Br J Clin Psychol 1996; 35:393\u2013397","DOI":"10.1111\/j.2044-8260.1996.tb01193.x"},{"key":"R1567BABDDCAA","doi-asserted-by":"crossref","unstructured":"Sobel W, Wolski R, Cancro R, Makari GJ: Interpersonal relatedness and paranoid schizophrenia. Am J Psychiatry 1996; 153:1084\u20131087","DOI":"10.1176\/ajp.153.8.1084"},{"key":"R1567BABBCAAC","doi-asserted-by":"crossref","unstructured":"Colonna L: Antideficit properties of neuroleptics. Acta Psychiatr Scand Suppl 1994; 380:77\u201382","DOI":"10.1111\/j.1600-0447.1994.tb05838.x"},{"key":"R1567BABBEJED","doi-asserted-by":"crossref","unstructured":"Kendler KS, Gruenberg AM, Tsuang MT: Outcome of schizophrenic subtypes defined by four diagnostic systems. Arch Gen Psychiatry 1984; 141:149\u2013154","DOI":"10.1001\/archpsyc.1984.01790130045006"}],"container-title":["American Journal of Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ajp.psychiatryonline.org\/doi\/10.1176\/ajp.156.7.1086","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,28]],"date-time":"2024-07-28T11:09:43Z","timestamp":1722164983000},"score":1,"resource":{"primary":{"URL":"https:\/\/psychiatryonline.org\/doi\/10.1176\/ajp.156.7.1086"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,7,1]]},"references-count":15,"journal-issue":{"issue":"7","published-print":{"date-parts":[[1999,7,1]]}},"alternative-id":["10.1176\/ajp.156.7.1086"],"URL":"https:\/\/doi.org\/10.1176\/ajp.156.7.1086","relation":{},"ISSN":["0002-953X","1535-7228"],"issn-type":[{"value":"0002-953X","type":"print"},{"value":"1535-7228","type":"electronic"}],"subject":[],"published":{"date-parts":[[1999,7,1]]}}}